These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37176022)

  • 1. Efficacy of a Multicomponent Nutraceutical Formulation for the Prevention and Treatment of Urinary Tract Stones.
    Maisto M; Schiano E; Luccheo G; Luccheo L; Alfieri E; Piccolo V; Iannuzzo F; Di Lorenzo R; Tenore GC
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis.
    Campos AH; Schor N
    Nephron; 1999; 81(4):393-7. PubMed ID: 10095174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
    PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Urtica dioica methanol extract against experimentally induced urinary calculi in rats.
    Zhang H; Li N; Li K; Li P
    Mol Med Rep; 2014 Dec; 10(6):3157-62. PubMed ID: 25310585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
    Freitas AM; Schor N; Boim MA
    BJU Int; 2002 Jun; 89(9):829-34. PubMed ID: 12010223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytotherapy and Herbal Medicines for Kidney Stones.
    Emiliani E; Jara A; Kanashiro AK
    Curr Drug Targets; 2021; 22(1):22-30. PubMed ID: 32990535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3].
    Okada Y; Kawamura J; Nonomura M; Kuo YJ; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
    Schwille PO; Manoharan M; Schmiedl A
    Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of urinary stone composition by infrared spectroscopy in the population of the European part of Russia].
    Smirnova VI; Lebedev DG; Lapin SV; Emanuel VL; E RV
    Urologiia; 2021 Dec; (6):20-24. PubMed ID: 34967159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.
    Baker PW; Rofe AM; Bais R
    Crit Rev Clin Lab Sci; 1996; 33(1):39-82. PubMed ID: 8833627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Risk Profile, Impact of Diet, and Risk of Calcium Oxalate Urolithiasis in Idiopathic Uric Acid Stone Disease.
    Siener R; Löhr P; Hesse A
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.
    Pak CY; Moe OW; Sakhaee K; Peterson RD; Poindexter JR
    J Urol; 2005 May; 173(5):1606-9. PubMed ID: 15821508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urolithiasis in Okinawa, Japan: a relatively high prevalence of uric acid stones.
    Hossain RZ; Ogawa Y; Hokama S; Morozumi M; Hatano T
    Int J Urol; 2003 Aug; 10(8):411-5. PubMed ID: 12887361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium corneum gigeriae galli extract inhibits calcium oxalate formation and exerts anti-urolithic effects.
    Wang N; Zhang D; Zhang YT; Xu W; Wang YS; Zhong PP; Jia TZ; Xiu YF
    J Ethnopharmacol; 2019 Mar; 231():80-89. PubMed ID: 30194056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.